HR. 1627In Committee
TREATS Act
Permanently allows telehealth prescribing of schedule III-V controlled substances for substance use disorder treatment without an in-person evaluation
Plain-English overview
What this bill does
Permanently allows telehealth prescribing of schedule III-V controlled substances for substance use disorder treatment without an in-person evaluation
Key points
- Authorize telehealth prescribing for schedule III V substances
- Allow audio only telehealth evaluations
Current status
Where it stands
Status
In Committee
Latest action
2025-02-26 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Related context
Topics and policy areas
undefinedDrug, alcohol, tobacco useHealthHealth technology, devices, suppliesMental health